-

Dr. Wayne A. I. Frederick Elected to Battelle Board of Directors

President of Howard University brings strong science-driven, health-oriented expertise to current and future innovation opportunities

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Dr. Wayne A. I. Frederick, current president of Howard University and the Charles R. Drew Professor of Surgery, has been elected to the Battelle Board of Directors. Initially, he will serve in an advisory role and become a full voting member in 2022.

Frederick was appointed the seventeenth president of Howard University in 2014 and has been responsible for advancing the university’s commitment to student opportunity, academic innovation, public service, and fiscal stability. He has overseen a series of reform efforts, including the expansion of academic offerings, establishing innovative programs to support student success and the modernization of university facilities.

He previously served as provost and chief academic officer.

“Wayne’s combination of medical expertise and business acumen will bring a unique and valuable perspective to Battelle’s board and help to advance Battelle’s mission,” said Board Chairman John Welch. “We’re delighted he’s joining us and look forward to his insights and contributions.”

“I’m honored and excited to join the Battelle board,” said Frederick. “Battelle is a unique organization bringing innovative technologies and solutions to rapidly changing markets including healthcare, environmental and national security. My stewardship of Howard University with its diverse pipeline of STEM researchers will complement Battelle’s mission. I look forward to being a part of this incredible organization as a member of its board.”

Frederick received his B.S and M.D. from Howard University. Following his post-doctoral research and surgical oncology fellowships at the University of Texas MD Anderson Cancer Center, he began his academic career as associate director of the cancer center at the University of Connecticut. Upon his return to Howard University, his academic positions included associate dean in the College of Medicine, division chief in the Department of Surgery, director of the Cancer Center and deputy provost for Health Sciences. He also earned a Master of Business Administration from Howard University’s School of Business in 2011.

“Wayne’s strong background in healthcare and medical education aligns so well with Battelle’s mission and strategic priorities,” said Battelle President and CEO Lou Von Thaer. “He will be a valuable addition to our board and I look forward to working with him for many years.”

Frederick is the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials and is a widely recognized expert on disparities in healthcare and medical education. His medical research focuses on narrowing racial, ethnic and gender disparities in cancer-care outcomes, especially pertaining to gastrointestinal cancers.

He currently serves on the Board of Directors for the Federal Reserve Bank of Richmond and Humana Inc.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle makes the world better by commercializing technology, giving back to our communities, and supporting science, technology, engineering and mathematics (STEM) education. For more information, visit www.battelle.org.

Contacts

Katy Delaney
(614) 424-7208
delaneyk@battelle.org

T.R. Massey
(614) 424-5544
masseytr@battelle.org.

Battelle


Release Versions

Contacts

Katy Delaney
(614) 424-7208
delaneyk@battelle.org

T.R. Massey
(614) 424-5544
masseytr@battelle.org.

More News From Battelle

Battelle Awarded Contract to Advance US Biological Threat Reduction

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, becoming the sole awardee for this major Biological Threat Reduction (BTR) effort. The award includes a $52.9 million base period, with a total potential value of $93.3 million over the full period of performance. The STEP 2.0 program operates under the Defense Threat Reduction Agency’s (DTRA) Global Threat Reduction (GTR) D...

Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals

COLUMBUS, Ohio--(BUSINESS WIRE)--The U.S. Environmental Protection Agency recently awarded Battelle one of three blanket purchase agreements to compete for research tasks to evaluate chemicals that may harm the endocrine system in animals and humans. Battelle and two other companies will bid on call orders with a total ceiling value of $44 million over five years to identify potential endocrine-disrupting chemicals and evaluate hazards, exposures, and risks to human health and the environment....

Decorated Senior Army Officer Tal Sullivan Joins Battelle

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Tal Sullivan, a highly decorated retired U.S. Army Special Forces (Green Beret) Colonel with more than 30 years of military and leadership experience, has joined the organization as Senior Program Director for Human Performance and Optimization within its Health Research Division. Sullivan brings a distinguished career spanning military operations, program management, and strategic consulting. Most recently, he oversaw major strateg...
Back to Newsroom